Fifth Annual Monroe E. Trout Premier Cares Award
The
Thunder Child Treatment Center,
Sheridan, WY
San Diego, CA -- The Thunder Child Treatment Center, Sheridan, Wyo., is the winner of the Fifth Annual Monroe E. Trout Premier Cares Award. Premier, the nation’s largest healthcare alliance enterprise, recently announced its Cares Award winner and runners-up during its Governance Education Conference held February 5-7 in Phoenix. More than 1,300 healthcare executives, trustees, medical leaders, and invited guests attended.
The Cares Award recognizes exemplary efforts that have improved the accessibility of healthcare services to the medically underserved and carries with it an annual cash award of $50,000 to the winner and $145,000 to be divided among five runners-up. One hundred and fifty-eight nominations for the award were received from healthcare organizations across the country.
Primary funding for the Cares Award was provided by Premier with additional funding coming from C.R. Bard, Inc., Sterling Diagnostics, Glaxo Wellcome, Becton Dickinson & Company, Merck, Johnson & Johnson, 3M, Mallinckrodt, Bristol-Myers Squibb, Eli Lilly, Standard Textile and UARCO.
"Grassroots community action is what the Cares Award is all about," said Robert W. O’Leary, Premier’s chairman and chief executive officer. "It recognizes innovative local efforts to help the medically underserved among us Ñ and underscores the importance of supporting these deserving efforts."
The recipients of the awards were chosen by a panel of national leaders selected from business, academe, labor, medicine, public health and consumer interests. The award is named after Monroe E. Trout, M.D., chairman from 1986-1994 of American Healthcare Systems, a predecessor organization to today’s Premier.
For 25 years, the Thunder Child Treatment Center has been providing chemical dependency treatment services to American Indians of Montana and Wyoming. The center is comprised of a coalition of nine federally recognized Native American tribes and specializes in treating this chronic and fatal disease and providing transitional treatment services to 11- to 18-year-olds from impoverished reservation communities.